经济参考报 记者 曾德金 近日，广州万孚生物技术股份有限公司（简称"万孚生物"，300482.SZ）发布的2025年度业绩预告预 计，2025年归属于上市公司股东的净利润为4600万元至6900万元，同比下降91.81%至87.71%；扣除非 经常性损益后的净利润为-1500万元至-750万元，同比下降103.02%至101.51%。 《经济参考报》记者注意到，这或将是万孚生物自2015年上市以来最差的业绩表现：2025年归属于上市 公司股东的净利润将创下上市以来新低，而年度扣除非经常性损益后的净利润将出现上市后首次亏损。 公司称，其海外市场业务稳健发展，将为公司整体的可持续增长提供支撑点。 万孚生物是"现场即时检测（POCT）"领域的龙头企业，主要业务聚集于医疗器械行业的体外诊断 （IVD）领域，专业从事快速诊断试剂及配套仪器的研发、生产智造、营销及服务。公司产品销往全球 150多个国家和地区。万孚生物于2015年在深圳证券交易所创业板上市，是国内POCT第一股。 万孚生物对2025年业绩变动的原因作了说明称，公司主营业务收入同比下滑，主要原因是国内收入下 滑，一方面增值税税率调整影响，另一方面院内业务受到 ...

万孚生物(300482)7月20日晚间公告，公司近日收到国家药监局颁发的人类微卫星不稳定性（MSI）检测 试剂盒（荧光PCR熔解曲线法）的医疗器械注册证。MSI检测对多种实体瘤患者有重要意义，包括林奇 综合征筛查、指５-FU类化疗药物的选择、预后分层和筛选免疫检查点抑制剂获益人群等。 ...

Group 1: Company Announcements - Chenfeng Technology plans to invest 90 million yuan in its wholly-owned subsidiary, Beiwang Zhican, to support its business development and create a new ecosystem for integrated power computing [1] - Daotong Technology's controlling shareholder proposes a mid-term dividend of 5.8 yuan per 10 shares for the year 2025 [4] - Huazheng New Materials' supervisors and executives plan to reduce their holdings by a total of no more than 124,900 shares [5] - Kuozi Jiao's controlling shareholder intends to reduce its stake by no more than 1.67% [9] - Rundu Co., Ltd.'s controlling shareholder plans to reduce its stake by no more than 3% [14] Group 2: Performance Forecasts - China First Heavy Industries expects a net loss of 90 million to 108 million yuan for the first half of 2025, an improvement from a net loss of 173 million yuan in the same period last year [2] Group 3: Shareholder Actions - China Xidian's shareholder, General Electric Singapore, plans to reduce its stake by no more than 3% [3] - Boguang New Materials' shareholder, Newhui Investment, plans to reduce its stake by no more than 1% [8] - Donghong Co., Ltd. has won a procurement project for pressure steel pipes and accessories worth 109 million yuan [6] - Tianshi Technology's wholly-owned subsidiary has resumed production after a temporary shutdown due to supplier issues [12] - Baichuan Co., Ltd.'s controlling shareholder has returned to work and is performing normal duties after being detained [13]